New approaches to treating diabetic peripheral polyneuropathy in children and adolescents
https://doi.org/10.14341/probl11715
Abstract
А hundred and seven patients (56 males and 51 females) aged 8 to 21 years who had suclinical and mild diabetic peripheral polyneuropathy received pathogenetic treatment. Thirty-nine patients took a combined drug including benfotiamine and pyridoxine in a daily dose of 300 mg for 6 weeks. Twenty-three and 45 patients were given a-lipoic acid in a daily dose of 10-15 mg/kg body weight for 8 and 12 weeks, respectively. The treatment was monitored by using the Total Symptoms Score and the Neuropathy Impairment Score for the Lower Extremities, stimulation electromyography of two nerves of the leg. The therapy showed significant positive changes in subjective and objective neurological symptoms and baseline altered indices, a good tolerability of all the drugs. The findings allow one to consider a-lipoic acid and "millegamma " as tablets to be an agent for the treatment of subclinical and mild forms of diabetic peripheral polyneuropathy.
About the Author
G. I. SivousRussian Medical Academy after graduation from the Ministry of Health of the Russian Federation
Russian Federation
References
1. Бустаманте Д., Лодж Д., Маркоччи Л. и др. // Международ. мед. журн. - 2001. - № 2. - С. 133-141.
2. Гехт Б. М. Теоретическая и клиническая электромиография. - Л., 1990.
3. Диагностика, лечение и профилактика диабетических осложнений у детей и подростков / Под ред. И. И. Дедова. М., 1997.
4. Строков И. А., Козлова Н. А., Мозолевский Ю. В. и др. // Журн. неврол. и психиатр. - 1999. - Т. 99, № 6. - С. 18-22.
5. Строков И. А., Новосадова М. В., Баринов А. Н., Яхно Н. Н. // Неврол. журн. - 2000. - № 5. - С. 14-19.
6. Строков И. А., Новосадова М. В., Баринов А. Н. и др. // Рус. мед. журн. - 2001. - Т. 9, № 7-8. - С. 314-317.
7. Duck S. С., Wei F., Parke J. et al. // Diabetes Care. - 1991. Vol. 14. - P. 292-386.
8. Dyck P. J., Davies J. L., Litchy W. J., O’Brien P. C. // Neurology. - 1997. - Vol. 49. - P. 229-239.
9. Effect of Treatment with the Antioxidant A-Lipoid Acid in Cardiac Autonomic Neuropathy in NIDDM Patients (DECAN Study) // Diabetes Care. - 1997. - Vol. 20, N 3. - P. 369-373.
10. Gleiter С. H, Schug B. S., Hermann R. et al. // Eur. J. Clin. Pharmacol. - 1996. - Vol. 50. - P. 513-514.
11. Hermann R., Gleiter С. H, Nibch G. et al. // Diabetes und Schtoffwechsel. - 1996. - Bd 5. - S. 5-11.
12. Loew D. // Clin. Pharmacol. Ther. - 1996. - Vol. 34, N 2. P. 47-50.
13. Neuropathies. Nerve Dysfunction of Diabetic and Other Origin / Ed. P. Kempler. - 1997. - P. 147-149.
14. Rosak C., Hoffgen P., Batles W. et al. // Diabetes und Schtoffwechsel. - 1996. - Bd 5. - S. 23-26.
15. Rosen P., Nawroth P. P., King G. et al. // Diabet. Metab. Rev. 2001. - Vol. 17. - P. 189-212.
16. Schaumburg И., Kaplan J., Rasmus S. et al. // Ann. Neurol. - 1982. - Vol. 12. - P. 107.
17. Stracke И., Lindermann A., Federlin K. // Exp. Clin. Endocrinol. Diabet. - 1996. - Vol. 104. - P. 311-316.
18. Ziegler D., Hanefeld M., Ruhnau K. J. et al. // Diabetologica. 1995. - Vol. 38. - P. 1425-1433.
19. Ziegler D., Reljanovic M., Mehnert H. et al. // Exp. Clin. Endocrinol. Diabet. - 1999. - Vol. 107. - P. 421-430.
Review
For citations:
Sivous G.I. New approaches to treating diabetic peripheral polyneuropathy in children and adolescents. Problems of Endocrinology. 2003;49(5):11-16. (In Russ.) https://doi.org/10.14341/probl11715
Views:
2012
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
